Hamilton Thorne Ltd. (HTL.TO)

1,3700 +0,0100 (+0,74%) Börsenschluss: 12:52PM EDT

Hamilton Thorne Ltd.

100 Cummings Centre
Suite 465E
Beverly, MA 01915
United States
800 323 0503
https://www.hamiltonthorne.ltd

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. David B. Wolf	Executive Chairman	734,01k	835,5k	N/A
Mr. Francesco Fragasso CPA	Chief Financial Officer	206,9k	N/A	N/A
Mr. Brett M. Fulton	Senior VP & GM	411,19k	N/A	N/A
Dr. Ekaterina Torchilin MBA, Ph.D.	President, CEO & Director	N/A	N/A	N/A
Mr. Thomas Kenny	Senior Vice President Global Operations & Sustaining Engineering and Management Rep	220,25k	N/A	N/A
Mr. Justin Jaundoo	Vice President of Corporate Development	N/A	N/A	N/A
Ms. Kimberly Marolda	Director of HR	N/A	N/A	N/A
Mr. Eric V. Dorman	President of Embryotech Laboratories Inc	N/A	N/A	N/A
Dr. Fabian Sell	Chief Executive Officer of Gynemed	386,45k	N/A	N/A
Mr. Dan Ryan	Finance Controller	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in CAD.

Beschreibung

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.

Corporate Governance

Hamilton Thorne Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.